Career Development Program in Omics of Lung Diseases (K12)
The summary for the Career Development Program in Omics of Lung Diseases (K12) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Career Development Program in Omics of Lung Diseases (K12): The long-term objectives of this program are to develop multidisciplinary career development programs that will equip new MD and PhD (or equivalent) investigators with the knowledge and skills to apply pan-omics and integrated approaches to elucidating genomic and molecular bases of lung disease, including heterogeneity, key regulatory networks, and relevant disease biomarkers, with the goal of advancing understanding of lung disease pathobiology and lung disease personalized medicine applications. The required expertise should include bioinformatics, experience in utilizing data from large cohorts and electronic medical records, techniques of integrative genomics and systems analysis, along with expertise, or at least familiarity, with clinical research and pulmonary medicine. Given the multidisciplinary nature of the research training, proposing multiple PD(s)/PI(s) is encouraged.
| Federal Grant Title: | Career Development Program in Omics of Lung Diseases (K12) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-HL-13-023 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.838 |
| CFDA Descriptions: | Lung Diseases Research |
| Current Application Deadline: | Oct 26, 2012 |
| Original Application Deadline: | Oct 26, 2012 |
| Posted Date: | Jul 26, 2012 |
| Creation Date: | Jul 26, 2012 |
| Archive Date: | Nov 26, 2012 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Viral INfections in the Young Lung- The VINYL Clinical Consortium- Data Analytics and Coor...
- • Viral INfections in the Young Lung- The VINYL Clinical Consortium (UG3/UH3 Clinical Trial ...
- • Limited Competition: Physician Scientist Transition to Independence in Blood Science Resea...
- • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
- • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
- • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
- • Lung Response to Inhaled Highly Toxic Chemicals
- • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
- More Grants from the National Institutes of Health
- • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...
- • Immune Tolerance Network (UM1 Clinical Trial Required)
- • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...
- • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...
- • Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...
